Macrogen Inc Asset Resilience Ratio

Latest as of September 2025: 3.56%

Macrogen Inc asset resilience ratio. Macrogen Inc (038290) has an Asset Resilience Ratio of 3.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Macrogen Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩12.17 Billion

≈ $8.25 Million USD Cash + Short-term Investments

Total Assets

₩341.60 Billion

≈ $231.50 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Macrogen Inc (2011–2024)

Asset resilience ratio of Macrogen Inc from 2011 to 2024. This chart shows how Macrogen Inc's Asset Resilience Ratio has changed over time. Read Macrogen Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Macrogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Macrogen Inc (038290) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩12.17 Billion	3.56%
Total Liquid Assets	₩12.17 Billion	3.56%

Asset Resilience Insights

Limited Liquidity: Macrogen Inc maintains only 3.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Macrogen Inc Industry Peers by Asset Resilience Ratio

Compare Macrogen Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pluristem TA:PSTI	Biotechnology & Medical Research	48.26%
Hadasit Bio TA:HDST	Biotechnology & Medical Research	57.00%
Purple Biotech Ltd TA:KTOV	Biotechnology & Medical Research	0.01%
Peptron Inc KQ:087010	Biotechnology & Medical Research	37.11%
Bioneer Corporation KQ:064550	Biotechnology & Medical Research	14.92%
MEDIPOST Co. Ltd KQ:078160	Biotechnology & Medical Research	0.72%
Cell Biotech Co. Ltd KQ:049960	Biotechnology & Medical Research	54.84%
Panagene Inc KQ:046210	Biotechnology & Medical Research	0.14%

Macrogen Inc Asset Resilience Ratio by Year (2011–2024)

Macrogen Inc asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Macrogen Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	12.93%	₩42.62 Billion ≈ $28.88 Million	₩329.66 Billion ≈ $223.41 Million	+3.11pp
2023-12-31	9.82%	₩25.31 Billion ≈ $17.15 Million	₩257.82 Billion ≈ $174.72 Million	-7.30pp
2022-12-31	17.12%	₩47.95 Billion ≈ $32.49 Million	₩280.13 Billion ≈ $189.84 Million	-3.08pp
2021-12-31	20.20%	₩60.84 Billion ≈ $41.23 Million	₩301.18 Billion ≈ $204.10 Million	+0.35pp
2020-12-31	19.85%	₩57.12 Billion ≈ $38.71 Million	₩287.79 Billion ≈ $195.03 Million	-4.98pp
2019-12-31	24.83%	₩56.00 Billion ≈ $37.95 Million	₩225.53 Billion ≈ $152.84 Million	-21.03pp
2018-12-31	45.86%	₩82.31 Billion ≈ $55.78 Million	₩179.50 Billion ≈ $121.64 Million	-0.95pp
2017-12-31	46.80%	₩83.64 Billion ≈ $56.68 Million	₩178.71 Billion ≈ $121.11 Million	+9.77pp
2016-12-31	37.03%	₩59.07 Billion ≈ $40.03 Million	₩159.52 Billion ≈ $108.11 Million	+8.74pp
2015-12-31	28.29%	₩38.00 Billion ≈ $25.75 Million	₩134.31 Billion ≈ $91.02 Million	-9.32pp
2014-12-31	37.62%	₩43.70 Billion ≈ $29.62 Million	₩116.18 Billion ≈ $78.73 Million	+6.83pp
2013-12-31	30.78%	₩27.00 Billion ≈ $18.30 Million	₩87.71 Billion ≈ $59.44 Million	-2.10pp
2012-12-31	32.88%	₩27.00 Billion ≈ $18.30 Million	₩82.12 Billion ≈ $55.65 Million	+4.31pp
2011-12-31	28.58%	₩16.50 Billion ≈ $11.19 Million	₩57.75 Billion ≈ $39.14 Million	--

pp = percentage points

About Macrogen Inc

KQ:038290 Korea Biotechnology & Medical Research

Market Cap

$74.70 Million

₩110.23 Billion KRW

Market Cap Rank

#20179 Global

#1080 in Korea

Share Price

₩11000.00

Change (1 day)

+0.92%

52-Week Range

₩10700.00 - ₩19520.00

All Time High

₩49726.89